| Lung cancer: current therapies and new targeted treatments FR Hirsch, GV Scagliotti, JL Mulshine, R Kwon, WJ Curran, YL Wu, ... The Lancet 389 (10066), 299-311, 2017 | 3089 | 2017 |
| A randomized trial of bevacizumab for newly diagnosed glioblastoma MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ... New England Journal of Medicine 370 (8), 699-708, 2014 | 3084 | 2014 |
| Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial DW Andrews, CB Scott, PW Sperduto, AE Flanders, LE Gaspar, ... The Lancet 363 (9422), 1665-1672, 2004 | 2996 | 2004 |
| National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1–3, 2000 National Institutes of Health Consensus Development Panel JNCI Monographs 2001 (30), 5-15, 2001 | 2320* | 2001 |
| Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non–small-cell lung cancer A Aupérin, C Le Péchoux, E Rolland, WJ Curran, K Furuse, P Fournel, ... Journal of clinical oncology 28 (13), 2181-2190, 2010 | 2224 | 2010 |
| Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or … JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ... The lancet oncology 16 (2), 187-199, 2015 | 2126 | 2015 |
| Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials WJ Curran Jr, CB Scott, J Horton, JS Nelson, AS Weinstein, AJ Fischbach, ... JNCI: Journal of the National Cancer Institute 85 (9), 704-710, 1993 | 1549 | 1993 |
| Sequential vs concurrent chemoradiation for stage III non–small cell lung cancer: randomized phase III trial RTOG 9410 WJ Curran Jr, R Paulus, CJ Langer, R Komaki, JS Lee, S Hauser, ... Journal of the National Cancer Institute 103 (19), 1452-1460, 2011 | 1442 | 2011 |
| Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402 G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ... Journal of clinical oncology 31 (3), 337-343, 2013 | 1289 | 2013 |
| A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database PW Sperduto, B Berkey, LE Gaspar, M Mehta, W Curran International Journal of Radiation Oncology* Biology* Physics 70 (2), 510-514, 2008 | 1181 | 2008 |
| Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy A Trotti, R Byhardt, J Stetz, C Gwede, B Corn, K Fu, L Gunderson, ... International Journal of Radiation Oncology* Biology* Physics 47 (1), 13-47, 2000 | 1132 | 2000 |
| Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ... Journal of clinical oncology 31 (32), 4085-4091, 2013 | 1118 | 2013 |
| Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma JC Buckner, EG Shaw, SL Pugh, A Chakravarti, MR Gilbert, GR Barger, ... New England Journal of Medicine 374 (14), 1344-1355, 2016 | 1076 | 2016 |
| Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and … W Sause, P Kolesar, S Taylor IV, D Johnson, R Livingston, R Komaki, ... Chest 117 (2), 358-364, 2000 | 921 | 2000 |
| Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group … E Shaw, R Arusell, B Scheithauer, J O’fallon, B O’neill, R Dinapoli, ... Journal of Clinical Oncology 20 (9), 2267-2276, 2002 | 890 | 2002 |
| Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group … G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ... Journal of Clinical Oncology 24 (18), 2707-2714, 2006 | 867 | 2006 |
| Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG … JR Simpson, J Horton, C Scott, WJ Curran, P Rubin, J Fischbach, ... International Journal of Radiation Oncology* Biology* Physics 26 (2), 239-244, 1993 | 710 | 1993 |
| Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresectable stage III NSCLC: RTOG 9410 WJ Curran Jr Proc Am Soc Clin Oncol 22, 621, 2003 | 695 | 2003 |
| Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial CA Meyers, JA Smith, A Bezjak, MP Mehta, J Liebmann, T Illidge, ... Journal of clinical oncology 22 (1), 157-165, 2004 | 691 | 2004 |
| Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with … L Souhami, W Seiferheld, D Brachman, EB Podgorsak, M Werner-Wasik, ... International Journal of Radiation Oncology* Biology* Physics 60 (3), 853-860, 2004 | 685 | 2004 |